Avicanna Inc.
$17,826,624.00
2,228,328.00 Common Shares at $8.00
Initial Public Offering - Closed - Wednesday, July 18, 2018
Company Description
Avicanna Inc. aims to establish itself as a leader in the global medical cannabis industry through its product discovery and development processes, intellectual property portfolio, strategic relationships, and cultivation infrastructure. With its two main business segments, namely R&D and cultivation, strategically position Avicanna to be a front runner in the development, manufacturing and commercialization of plant-derived cannabinoid-based products and extracts throughout North America, Latin America, Europe and Asia.
| Address: |
MaRS Centre, West Tower, 661 University Avenue, Suite 1300 Toronto, Ontario, M5G 0B7 Canada |
|---|---|
| Phone Number: | 647 243 5283 |
| Fax Number: | |
| Website: |
| Industry: | Biotechnology |
|---|---|
| Closing Date: | Wednesday, July 18, 2018 |
| 1st Day of Trading: | Thursday, July 18, 2019 |
| Primary Symbol: | AVCN |
| Exchange: | TSX |
Proceeds
The net proceeds of the offering will be used for the completion of cultivation infrastructure in Colombia, research and development, marketing activities, human capital, technical transfers and unallocated working capital.
| Gross Proceeds: | $17,826,624.00 |
|---|---|
| Underwrting Fees: | $670,800.00 |
| Expense Offering: | $135,000.00 |
| Net Proceeds: | $17,020,824.00 |
| Lead Underwriter: | Sprott Capital Partners LP |
|---|---|
| Other Underwriter(s): | Paradigm Capital Inc. |
Performance
| 1 day | 1 week | 1 month | 6 months | Inception | |
|---|---|---|---|---|---|
| Recent Performance | 0.00 % | -4.08 % | 11.90 % | -16.07 % | -97.06 % |
| Post IPO Performance | -22.13 % | -22.13 % | -70.00 % |
The content of this page is transmitted strictly for informational purposes. Investments must be selected in accordance with the investor's respective objectives. Desjardins Online Brokerage does not issue any recommendations or endorsements concerning any particular product, its potential value or appropriateness, or any specific strategy. It is highly recommended to read the prospectus before making any type of investment.